Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 2Phase 3 2Phase 1 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Neoplasms 1Leukoplakia, Oral 1Coproporphyria 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × Sulindac × Clear all
NCT00299195 2020-11-19

A Randomized Study of Sulindac in Oral Premalignant Lesions

Memorial Sloan Kettering Cancer Center

Phase NA Completed
63 enrolled 10 charts
Head & Neck

Coproporphyria, Leukoplakia, Oral, Neoplasms

NCT00343629 2015-04-28

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

National Cancer Institute (NCI)

Phase NA Completed
28 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡